Market News How it works Learn FAQ
| GPUS 0.1689 34.05% | XXII 0.1977 -8.34% | SHFS 0.1324 -61.39% | NVD 4.19 0.96% | LUCD 0.411 25.42% | SPCX 147.49 1.89% | T 20.93 -7.96% | SOXL 83.56 1.77% | NU 15.16 2.92% | NOK 8.14 3.30% | EWZ 42.59 1.77% | NVDA 210.96 -0.59% | RIME 0.106 -12.90% | INTC 86.96 1.72% | TSLG 4.87 -1.62% | AAL 12.11 -3.89% | BBD 4.07 3.04% | STLA 4.06 -4.81% | SOXS 52.46 -1.85% | RWM 14.55 0.34% | HYG 77.05 -0.06% | MYND 0.24 47.42% | BITO 10.83 -0.28% | SPDN 8.54 0.47% | YFOR 0.2236 -1.58% | RBNE 0.19 -2.56% | TQQQ 66.29 -0.20% | VZ 44.66 -1.19% | TSLL 9.76 -1.21% | SPTI 27.63 -0.11% | YMAT 2.05 6.77% | CRWV 54.235 -2.46% | INFY 12.35 -6.58% | RIG 6.41 5.43% | F 11.6 -2.85% | SQQQ 39.68 0.20% | AIOK 12.02 182.82% | ONDS 6.2 2.99% | AAPL 347.725 -0.14% | LABT 0.31 -36.67% | CDE 13.45 -3.10% | PCG 12.63 -2.70% | GRAB 2.79 -2.11% | SOFI 14.615 -1.05% | XLE 69.33 2.60% | IREN 24.905 -2.37% | QID 14.55 0.14% | RKT 11.73 -0.09% | WULF 11.32 0.00% | BE 193.3 -11.24%
ARAccuray Incorporated logo

Accuray Incorporated (ARAY)

NASDAQ Global Select · Currency in USD
$0.13 ▼ 0.00 (-2.91%)
At close: Oct 23, 4:00 PM ET. Market closed.
$0.13 ▲ +0.00 (+3.61%)
After hours: Oct 23, 7:22 PM ET

Summary

Previous Close
$0.13
Open
$0.13
Day's Range
$0.13 – $0.14
52 Week Range
$0.13 – $1.60
Volume
1,042,966
Avg. Volume
5,756,175
Market Cap
$15.54M
Beta (5Y Monthly)
1.42
PE Ratio (TTM)
--
EPS (TTM)
-$0.40
Earnings Date
Nov 4, 2026
Forward Dividend & Yield
--
Ex-Dividend Date
--
1y Target Est
$2.00

Profile: Accuray Incorporated

Sector
Healthcare
Industry
Medical - Devices
Full-time employees
809
CEO
Stephen R. LaNeve

Accuray Incorporated specializes in the design, development, production, and sale of advanced radiosurgery and radiation therapy equipment aimed at treating tumors. Their market footprint spans across North and South America, Australia, New Zealand, Europe, the Middle East, India, Africa, Japan, China, and the broader Asia Pacific region. Among their core offerings is the CyberKnife System, a sophisticated robotic platform for stereotactic radiosurgery and stereotactic body radiation therapy.

Earnings

Next report: Wed, Nov 4, 2026
EPS estimate -$0.07 · Revenue est. $95.80M
DateEst.Actual
Aug 19, 2026-$0.03-$0.02Beat
May 6, 2026-$0.05-$0.09Miss
Feb 4, 2026-$0.11-$0.11Miss
Nov 5, 2025-$0.01-$0.18Miss
Aug 13, 2025$0.03$0.01Miss
Apr 30, 2025-$0.05-$0.01Beat

Analyst view

Consensus price target
$2.00 ▲ +1,437.3%
Range $2.00 – $2.00
Rating: Buy
Buy 62% · Hold 31% · Sell 8%

Get free alerts on ARAY and big market moves

Free special alerts by text & email on new investment opportunities, buyouts and the stocks moving most, in plain English.
Get free stock alerts →
Data: Financial Modeling Prep. For information only, not investment advice.